EPIXD

MarketResearch.com: "EPIX Pharmaceuticals, Inc.-Deals & Alliances Report" by Life Science Analytics (LSA) April 2008 - 04/30 - 05:37 AM ET

UPDATE: EPIX Pharmaceuticals to end PRX-00023 clinical development program - 03/20 - 11:16 AM ET

EPIX Pharmaceuticals to end PRX-00023 clinical development program - 03/20 - 08:17 AM ET

EPIX Pharmaceuticals revises results for Alzheimer's drug trial - 01/16 - 08:58 AM ET

EPIX PHARMACEUTICALS UP 55% AT $4.60 IN PREMARKET TRADING - 12/18 - 10:06 AM ET

EPIX Pharma reports promising results from PRX-03140 in Alzheimer's disease - 12/18 - 08:53 AM ET

EPIX Pharma says 1b trial of PRX-07034 shows 'significant' weight loss - 10/29 - 10:03 AM ET

<< Back to Stock Index

Most Popular News

PREMIER SPONSORED LINKS

TRADE CENTER

The TradingMarkets Directory

Stocks

Options

Forex

E-mini/Futures

How to Trade

Tools

PowerRatings

Trading Contests

Premium Subscription Services

Short Term PowerRatings

Free Trial

Long Term PowerRatings

Free Trial

TradingMarkets Subscription

Free Trial

Daily Battle Plan

Free Trial

Gary Kaltbaum - Intraday Breaking Alerts

Free Trial

Kevin Haggerty Professional Trading Service

Free Trial

Forex Force with Mark Whistler

Free Trial

RELATED SITES

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.